Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Adam Mendelsohn
Adam Mendelsohn is recorded as CEO and Board Member at Vivani Medical, Inc. (VANI). Vivani Medical, Inc. reported in an 8-K filed June 30, 2026 that Adam Mendelsohn was appointed Director, effective June 24, 2026. Vivani Medical, Inc. reported in an 8-K filed September 2, 2022 that Adam Mendelsohn was appointed director, effective August 30, 2022. Vivani Medical, Inc. reported in an 8-K filed September 2, 2022 that Adam Mendelsohn was appointed Chief Executive Officer, effective August 30, 2022. The proxy statement of Vivani Medical, Inc. reports total compensation of $877,580 for Adam Mendelsohn in fiscal 2025, including a base salary of $610,000. Disclosed compensation is on record for 5 fiscal years. Adam Mendelsohn has spoken on 1 investor event across 1 company, most recently for Vivani Medical, Inc. on June 4, 2026.
“The stockholders elected each of the six director nominees to the Board to serve until Vivani's 2027 annual meeting of stockholders or until their earlier death, resignation or removal, or until their successors have been duly elected and qualified, as set forth below:”
Vivani Medical, Inc. Form 8-K, filed June 30, 2026
· Read the filing
“On and as of the Effective Date, the Board appointed Adam Mendelsohn as a director of the Company.”
Vivani Medical, Inc. Form 8-K, filed September 2, 2022
· Read the filing
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
